AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06372938 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Laboratory Tests and Inflammatory Markers
Description: The laboratory values were measured at the time of FGR diagnosis (between 32 and 37 weeks of pregnancy). After evaluation of hemoglobin (g/dl), leukocytes (103/μL), monocytes (103/μL), lymphocytes (103/μL), neutrophils (103/μL), platelets (103/μL) and albumin (g/dl), the inflammation values were calculated as follows: ;~* SII = Absolute platelet count (APC)\* Absolute neutrophil count (ANC) / Absolute lymphocyte count (ALC);~* SIRI = Absolute monocyte count (AMC) \* ANC/ ALC;~* NPAR = Proportion of neutrophils (in total leukocytes) (%) × 100/albumin (g/dL).
Study NCT05165355 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Furmonertinib
Description: Furmonertinib (80 mg orally, once daily) for 3 years.
Study NCT05754073 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 1. Intranasal oxytocin spray
Description: 30 IU, twice daily for 12 months in the experimental arm in double-blinded phase
Study NCT05754073 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: 2. Intranasal placebo spray
Description: 30 IU, twice daily for 12 months in the placebo comparator arm in double-blinded phase
Study NCT05754073 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 3. Intranasal Oxytocin spray
Description: 30 IU, twice daily for 6 months in both experimental and placebo comparator arm in open-label phase
Study NCT05754073 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: 3. Intranasal Oxytocin spray
Description: 30 IU, twice daily for 6 months in both experimental and placebo comparator arm in open-label phase
Study NCT06155747 — intervention group
Intervention type: OTHER
Intervention: Epidemiologic investigation
Description: Identification of:~1. overlaps in source(s) of care between participants with NTM isolates in a healthcare center.~2. environmental NTM isolates that are highly related to respiratory isolates.~3. common water source exposure among subjects with clustered NTM infections via shared home of residence watershed.
Study NCT05486026 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Duloxetine 30 MG
Description: patient in first group (case) will receive duloxetine tablet 30mg for two weeks then titrated up to duloxetine 30mg BID. Patients will be instructed to take the medication with meals. The for 13 weeks
Study NCT05486026 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nonsteroidal Antiinflammatory Drug
Description: patient in this second group will receive NSAID for 3 weeks
Study NCT05146804 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: BroccoCress
Description: BroccoCress® is a brand name for an edible plant, broccoli sprouts. BroccoCress® is a product within the group of vegetable sprouts.
Study NCT05146804 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Affilla Cress
Description: Pea sprouts commercially available as Affilla Cress® will be used as placebo in this study since these sprouts do not contain Glucoraphanin/Sulforaphane.
Study NCT05671783 — intervention group
Intervention type: OTHER
Intervention: Hemodynamic observation of the patients.
Description: For the purposes of this study, we defined intraoperative hypotension as a decrease in mean blood pressure of 30% from baseline for a minimum of 5 minutes, including induction and maintenance of anesthesia. The measuring blood pressure method (noninvasive or invasive) depended on the surgical intervention's invasiveness and the patient's cardiac performance.~As soon as the patients entered the PACU, the responsible nurses started the standard monitoring. Anesthesiologists constantly oversee all actions based on the patient's condition. Clinical observation for respiratory and gastrointestinal problems and all disorders were monitored. When in room air SO2 was \<94, we started oxygen treatment with a 4 liter/minute nasal cannula, and in cases of nausea antiemetic was administered. The Modified Aldrete Score was used to discharge the patent.
Study NCT04654481 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: HCFWO
Description: The Afflovest device is a High Frequency Chest Wall Oscillation (HFCWO) device, a medical vest that uses vibrations to loosen and mobilize mucus in the lung secretions and help clear the airways.
Study NCT04654481 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard Care Plus Monitoring
Description: Monitoring via home spirometry, pulse oximetry, temperature checks, telehealth check-in and patient-reported outcome assessments.
Study NCT04654481 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard Care Plus Monitoring
Description: Monitoring via home spirometry, pulse oximetry, temperature checks, telehealth check-in and patient-reported outcome assessments.
Study NCT05374382 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Strengthening
Description: 3x/w, 9 wks supervised strengthening program, during prehabilitation to ACL surgery
Study NCT05374382 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Conventional
Description: Participants received a 9-weeks conventional prehabilitation program (targeting pain knee mobility) before ACL reconstruction, followed by a standardized post-operative rehabilitation program
Study NCT04506814 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Endocardial PVI
Description: Catheter based PVI
Study NCT04506814 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Epicardial Posterior Wall Isolation + LAA Exclusion + Endocardial PVI
Description: Minimally invasive PVI with posterior wall RF ablation + LAA clip + endocardial PVI
Study NCT05744622 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: KetacTM Universal AplicapTM
Description: chemically cured conventional GICs
Study NCT05744622 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: KetacTM Universal AplicapTM with light cure
Description: chemically cured conventional GICs with light curing enhancement
Study NCT05811715 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: whole body stretching excercise
Description: For the WBS group, each 30 minutes exercise class was run by a one trained physiotherapist to serve a maximum of 10 participants (10 x 3 = 30 participants) working in the hospital. Participants invited to attend the exercise class 3 times a week for 6 weeks in their hospital during lunch-break. During each session, participants asked to perform WBS exercise (Franco et al., 2008).
Study NCT05811715 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: educational program
Description: Participants received an education program which includes ergonomic principles, WRMSDs and their risk factors, as well as manual handling techniques(Bolbol et al., 2017).
Study NCT05811715 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: educational program
Description: Participants received an education program which includes ergonomic principles, WRMSDs and their risk factors, as well as manual handling techniques(Bolbol et al., 2017).
Study NCT04969445 — intervention group
Intervention type: BIOLOGICAL
Intervention: Recombinant Human Papillomavirus Bivalent (Types 16, 18) Vaccine (Escherichia coli)
Description: The bivalent HPV-16/18 vaccine was a mixture of two aluminum hydroxide adjuvant-absorbed recombinant L1 VLPs of HPV-16 and HPV-18 expressed in E. coli. A 0.5 ml dose of the bivalent HPV test vaccine comprised 40 μg of HPV-16 and 20 μg of HPV-18 L1 VLPs absorbed with 208 μg of aluminum adjuvant
Study NCT05315050 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Educational session and Information Pamphlet
Description: Each session will last for 50 minutes that will consist on lecturing, discussion about improving adolescent girls' menstrual knowledge, promoting a more positive attitude, encourage confidence, self-care behavior, physical activity and improve pain relief practice.~Exercise advice: The exercise protocol will include aerobic exercise such as jogging, which perform in the interventional group, three times a week, and for 10 to 30 min.~Stretching's advice: Piriformis stretching (5 repitition×20seconds), Cobra Pose. (5 repitition×20seconds), Adductor stretching. (5 repitition×20seconds), Sit up (10 repetition × 3 sets), Bridge exercise (10 repetition × 3 sets), Kegel exercise (10repetition × 3 sets), Pelvic eleva¬tion (10repetition × 3 sets), three times a week.
Study NCT05315050 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Information Pamphlet
Description: Pamphlets consist of information about primary dysmenorrhea its causes, symptoms (onset, duration, location, prognosis) and treatment strategies (taking hot bath, heating pad, yoga, exercise, maintaining hygiene, modifying life style) Emphasized on that menstruation is a not a disease it's a natural life experience.
Study NCT04973579 — intervention group
Intervention type: PROCEDURE
Intervention: Simutaneous (single anaesthesia) carotid artery stenting with MicroNet covered stent (CGuard) and cardiac surgery (CABG or surgical valve replacement / repair procedure)
Description: The registry enrolls patients qualified for treatment with the methods evaluated in the registry, using routinely applicable procedures and devices.~In cardiac surgery - surgical treatment systems for advanced ischemic heart disease and/or valvular disease (including - mechanical/biologic heart valves - regulatory approved for routine use and typically used at the Facility.~In the simultaneous treatment of stroke-threatening carotid artery atherosclerosis - temporary neuroprotection systems (proximal, distal, according to medical indications and local experience) - regulatory approved for routine use and typically used at the center (for over 20 years).~CGuard anti-embolic mesh stent system - a self-expanding nitinol carotid stent wrapped in MicroNet, which prevents fragments of atherosclerotic plaque from entering the lumen of the carotid artery - approved for routine use and typically used at the Center (over 5 years).
Study NCT06238674 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: indirect calorimetry and nitrogen balance
Description: nutrition therapy with energy guided by indirect calorimetry measurements and total protein guided by nitrogen balance with the maximum of 1.3 g/kg/d~, repeated indirect calorimetry if renal replacement therapy was initiated and follow up of urea nitrogen balance after 7 days of intervention to guarantee positive nitrogen balance
Study NCT06238674 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Indirect calorimetry (Standard care nutrition arm)
Description: indirect calorimetry measurements using the Q-NRG+ device will be conducted and urea nitrogen balance were measured . In the standard care nutrition arm, clinicians will be blinded to indirect calorimetry and urea nitrogen balance measurements
Study NCT06065176 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Novavax COVID-19 vaccine (2023-2024 formula XBB containing)
Description: Participants will receive a single dose of the Novavax vaccine.
Study NCT06065176 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Pfizer COVID-19 mRNA vaccine (2023-2024 formula XBB containing)
Description: Participants will receive a single dose of the Pfizer vaccine.
Study NCT05889455 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sildenafil
Description: Oral administration of 100mg
Study NCT05889455 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT06493539 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care group
Description: The control group will receive standard of care wound treatment
Study NCT06493539 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CINPWT
Description: Subject will receive CINPWT until discharged
Study NCT05053516 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: A standardized training program for social workers
Description: A standardized training program for social workers who work with drug addicts / drug users based on industry needs
Study NCT06234150 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aerobic dance
Description: Patients assigned to the aerobic dance group will participate in a one-on-one training session before their first chemotherapy session, including aerobic dance instruction, teleconference participation, use of a heart rate bracelet, and use of the Perceived Exertion Rating (PRE) until they master all components. The researchers will also provide participants with instructional videos to view anytime. We will require an exercise log to record the number of workouts, the intensity of the workout using the PRE and heart rate, and the presence of adverse effects. An experienced physical therapist will remotely supervise patients via teleconferencing at home. They will exercise for 50 min three times per week for 12 weeks. The physiotherapist monitors the patient\&amp;#39;s heart rate throughout the exercise program and provides feedback on any problems encountered during exercise.
Study NCT06234150 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Fast-walking
Description: Patients assigned to the fast-walking group will participate in a one-on-one training session before their first chemotherapy session, including fast-walking instruction, teleconference participation, use of a heart rate bracelet, and use of the Perceived Exertion Rating (PRE) until they master all components. The researchers will also provide participants with instructional videos to view anytime. We will require an exercise log to record the number of workouts, the intensity of the workout using the PRE and heart rate, and the presence of adverse effects. An experienced physical therapist will remotely supervise patients via teleconferencing at home. They will exercise for 50 min three times per week for 12 weeks. The physiotherapist monitors the patient\&amp;#39;s heart rate throughout the exercise program and provides feedback on any problems encountered during exercise.
Study NCT05411549 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Diet Modification to Adopt Mediterranean Diet
Description: Participants enrolled in group 1 will be counselled by a dietician and asked to adopt a Mediterranean diet for a 12-week period from counselling. Participants will complete a series of Mediterranean Diet Adherence Score, pain questionnaires as well as quality of life questionnaires (EPH-30, SF-36, GIQLI) which have been previously validated. Participants in this group will give a baseline and final visit blood sample and stool samples to assess inflammation biomarkers as well as gut microflora.
Study NCT05102578 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Digital Decision Aid Tool
Description: The digital DAT will ask people about their current pain levels, medications and physical activity. Following this, it will include a Discrete Choice Experiment (DCE)-like component with a series of questions that ask users to choose between different pain management packages. Similar to a standard DCE, packages (or plans) are described by attributes and levels, which include broad categories of guideline-based pain management strategies routinely available in clinical practice. The descriptors used for the attributes and levels were informed by a previous qualitative research study and based on therapeutic options that are helpful and important to people with persistent pain .
Study NCT06116227 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Whole Body Vibration Training Plus Conventional Physical Therapy Exercise Program.
Description: Patients in the study group will receive the traditional physical therapy program first, followed immediately by whole-body vibration training on the vibration platform (Power Plate International, Irvine, California, USA) at the same visit. The vibration frequency will be 30 Hz and the amplitude will be from 4 to 7 mm, with an increase of 1mm every two weeks. The WBV program was three sessions a week for eight weeks. WBV duration starts with 10 min in the 1st week and up to 25 min in the 8th week, with a regular increase of five minutes after every two successive weeks.
Study NCT06116227 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional Physical Therapy Exercise Program.
Description: The program will include 60 minutes of a supervised and individualized exercise program, including stretching exercises for the Calf and hamstring muscles, followed by strengthening exercises for hip, knee, ankle, and foot muscles, and scar management techniques to avoid scar or contracture formation.
Study NCT05661227 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Description: Whether apply DEX or not
Study NCT05661227 — intervention group
Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: 0.9% Sodium chloride
Description: Whether apply DEX or not
Study NCT05661227 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Tourniquet(Early)
Description: Timing of tourniquet application
Study NCT05661227 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Tourniquet(Late)
Description: Timing of tourniquet application
Study NCT05188820 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: PRP - platelet rich plasma injection
Description: Facet block using PRP
Study NCT05188820 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Cortisone injection
Description: Facet block using cortisone
Study NCT05864742 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ibrutinib
Description: 560 mg daily continuously
Study NCT05864742 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Venetoclax
Description: Oral daily. Dose escalation every 7 days (if no TLS) 20mg, 50mg, 100mg, 200mg and 400mg
Study NCT05864742 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Navitoclax
Description: Oral daily. Dose-escalation every 14 days (if plt >75x10\^9/L) 50mg, 100mg, 150mg, and 200mg (target dose)
Study NCT05864742 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rituximab
Description: 375mg/m2, intravenous. To be given on day 1 of weeks 1, 2, 3, 4 of C1 and day 1 of C2-C8
Study NCT06343935 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Linperlisib
Description: Linperlisib is a small molecule inhibitor of phosphoinositol 3-kinase-δ (PI3K-δ)
Study NCT05533879 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Tele-yoga
Description: Women with chronic low back pain will be taken to group-based Tele-Yoga sessions of 60 minutes three times a week for 4 weeks, in an internet-based telerehabilitation environment.
Study NCT05014334 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Berberine
Description: berberine 500 mg, twice daily for 14 days
Study NCT05014334 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vonoprazan
Description: Vonoprazan 20 mg, twice daily for 14 days
Study NCT05014334 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Vonoprazan
Description: Vonoprazan 20 mg, twice daily for 14 days
Study NCT05014334 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amoxicillin
Description: amoxicillin 1000mg, twice daily for 14 days.
Study NCT05014334 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Amoxicillin
Description: amoxicillin 1000mg, twice daily for 14 days.
Study NCT05014334 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Rabeprazole
Description: Rabeprazole 10mg, twice daily for 14 days.
Study NCT05014334 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bismuth
Description: Bismuth 220mg, twice daily for 14 days.
Study NCT05014334 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Clarithromycin
Description: clarithromy 500mg, twice daily for 14 days.
Study NCT06417112 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Transthoracic Echocardiogram
Description: All participants have been referred for a transthoracic echocardiogram by a clinician.
Study NCT05798130 — intervention group
Intervention type: OTHER
Intervention: No intervention group.
Description: No intervention group.
Study NCT05159154 — intervention group
Intervention type: DEVICE
Intervention: Myocardial Work
Description: Myocardial work (MW) is emerging as an alternative tool for studying LV myocardial systolic function, because it incorporates both deformation and load into its analysis. In this context, MW could be considered as an advancement of myocardial strain, allowing to investigate LV performance also in cases of changes in afterload that could lead to misleading conclusions if relying only on strain analysis. This parameter will be evaluated by using an echographer equipped with a specific software for the analysis (Ecog Vivid E95 Ultra GE®)
Study NCT06036251 — intervention group
Intervention type: OTHER
Intervention: Questionnaires
Description: Self-reported quality of life (QOL) measures completed online
Study NCT05693168 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ANNE Limb Sensor
Description: Pulse Oximeter
Study NCT02126033 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: take blood samples
Study NCT05614687 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Community-informed art-based programme
Description: The Community-informed art-based programme is an intervention incorporating art in the form of for example poetry and drawings in addressing trauma and encouraging community attitudes towards the positive reintegration of ex-offenders.
Study NCT05614687 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Government Media Intervention
Description: Government Media Intervention involving media content from the National Orientation Agency and other media sources
Study NCT04941066 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Active neurofeedback
Description: The session will be done on an individual basis. The active group will receive neurofeedback training from the rumination-related brain functional connectivity.
Study NCT04941066 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Sham neurofeedback
Description: The session will be done on an individual basis. The sham group will receive neurofeedback training from an artificially generated random feedback signal.